A retrospective study of Medicare data showed a potential factor in nonadherence to oral cancer treatment regimens.
A review of studies revealed a gap in the data used to assess adherence to TKI treatment for chronic myeloid leukemia.
Tyrosine kinase inhibitors have improved survival outcomes for patients with CML, but these agents also have a greater risk for adverse cardiovascular events.
A review of data from patients with CML treated with TKIs identified risk factors for developing pulmonary hypertension in these patients.
Researchers seek to characterize adherence trajectories, determine how side effects or financial status influence adherence, assess how adherence effects clinical outcomes, and explore unique patient perspectives.